Search clinical trials for: Xospata
Total 21 results
-
Children's Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia | AML, ChildhoodChina
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
Kura Oncology, Inc.RecruitingNeoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL RearrangementUnited States
-
St. Jude Children's Research HospitalAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonRecruiting
-
Centre Antoine LacassagneAcute Leukemia French AssociationNot yet recruiting
-
Chen SuningRecruitingChemotherapy Effect | AML, AdultChina
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationUnited States
-
Astellas Pharma Korea, Inc.RecruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia | FLT3-mutated Acute Myeloid LeukemiaJapan, Korea, Republic of, Taiwan
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Kronos BioTerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States, Spain
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Vadim S KoshkinEli Lilly and Company; Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Castration-resistant Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Ayman H QasrawiAstellas Pharma IncWithdrawn
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid LeukemiaUnited States